Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP

@article{Kang2007IrinotecanPC,
  title={Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP},
  author={Hye Jin Kang and Won Seog Kim and Cheolwon Suh and Yeon Hee Park and Bong Seog Kim and Young Jin Yuh and B Ryoo},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2007},
  volume={62},
  pages={299-304}
}
The therapeutic strategy for relapsed or refractory patients with diffuse large B-cell lymphoma (DLBL) remains challenging yet. Salvage therapy has been tried for these patients according to their clinical status. We studied ICD (irinotecan, cisplatin and dexamethasone) regimen as salvage chemotherapy for DLBL patients previously treated with RCHOP. Between… CONTINUE READING